RECRUITING

Preventing T2DM After GDM With Immediate Postpartum Screening

Description

The overall goal of this proposal is to create and test an implementation protocol for in-hospital immediate postpartum diabetes screening for postpartum patients with pregnancies affected by GDM.

Conditions

Gestational DiabetesType 2 Diabetes
Talk to us

Related Conditions:

Gestational DiabetesType 2 Diabetes

Study Overview

On this page

Study Details

Study overview

The overall goal of this proposal is to create and test an implementation protocol for in-hospital immediate postpartum diabetes screening for postpartum patients with pregnancies affected by GDM.

Preventing Type 2 Diabetes Mellitus After Gestational Diabetes Mellitus With Immediate Postpartum Screening

Preventing T2DM After GDM With Immediate Postpartum Screening

Condition
Gestational Diabetes
Intervention / Treatment

-

Contacts and Locations

Worcester

University of Massachusetts Memorial Medical Center, Worcester, Massachusetts, United States, 01605

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * pregnancy complicated by GDM as diagnosed with traditional two step testing in the third trimester according to Carpenter-Coustan Criteria
  • * receiving prenatal care at UMASS Memorial and plans to deliver at UMASS Memorial
  • * able and willing to provide informed consent
  • * ability to complete immediate in hospital postpartum glucose testing
  • * have evidence of impaired glucose metabolism defined as fasting glucose value of ≥126 mg/dL or 2-hour glucose value of ≥200 mg/dL
  • * known diagnosis of pre-existing pre-gestational diabetes in pregnancy
  • * inability to complete oral glucose tolerance test (e.g. gastric bypass surgery history, gastric dumping syndrome history, vomiting of oral glucose tolerance test) in pregnancy or immediately postpartum
  • * systemic steroid use

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Massachusetts, Worcester,

Gianna Wilkie, MD, PRINCIPAL_INVESTIGATOR, UMASS Memorial Healthcare

Study Record Dates

2028-12-01